ACQUIRED · 2019
Who Acquired Osiris Therapeutics, Inc.?
Smith & Nephew · $660.0M· 28.8× EBITDA
The acquisition
Osiris Therapeutics, Inc. was acquired by Smith & Nephew in 2019 for $660.0M. The deal was priced at 28.8× EBITDA / 4.20× revenue.
Osiris Therapeutics, Inc. at time of acquisition
Revenue
$157.4M
EBITDA
$22.9M
Deal value
$660.0M
EV / EBITDA
28.8×
Other acquisitions by Smith & Nephew
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Integra LifeSciences' Extremity Orthopaedics Business · 2021 · $236.0M
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from SEC Fairness Opinion. Primary source. Full deal page.
Citation: ExitValue.ai. (2019). Osiris Therapeutics, Inc. acquired by Smith & Nephew. https://exitvalue.ai/acquired/osiris-therapeutics-inc